ECT Stock Overview
A publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Eurocastle Investment Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €7.10 |
52 Week High | €8.65 |
52 Week Low | €6.60 |
Beta | 0.42 |
11 Month Change | 1.43% |
3 Month Change | -2.07% |
1 Year Change | -4.05% |
33 Year Change | -16.47% |
5 Year Change | -3.27% |
Change since IPO | -99.80% |
Recent News & Updates
Recent updates
Shareholder Returns
ECT | NL Real Estate | NL Market | |
---|---|---|---|
7D | 0% | 0.2% | -0.9% |
1Y | -4.1% | 22.9% | 25.4% |
Return vs Industry: ECT underperformed the Dutch Real Estate industry which returned 22.9% over the past year.
Return vs Market: ECT underperformed the Dutch Market which returned 25.4% over the past year.
Price Volatility
ECT volatility | |
---|---|
ECT Average Weekly Movement | 3.9% |
Real Estate Industry Average Movement | 4.1% |
Market Average Movement | 4.2% |
10% most volatile stocks in NL Market | 7.4% |
10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: ECT has not had significant price volatility in the past 3 months compared to the Dutch market.
Volatility Over Time: ECT's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.eurocastleinv.com |
Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager.
Eurocastle Investment Limited Fundamentals Summary
ECT fundamental statistics | |
---|---|
Market cap | €7.11m |
Earnings (TTM) | -€371.00k |
Revenue (TTM) | €628.00k |
11.3x
P/S Ratio-19.2x
P/E RatioIs ECT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ECT income statement (TTM) | |
---|---|
Revenue | €628.00k |
Cost of Revenue | €0 |
Gross Profit | €628.00k |
Other Expenses | €999.00k |
Earnings | -€371.00k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.37 |
Gross Margin | 100.00% |
Net Profit Margin | -59.08% |
Debt/Equity Ratio | 0% |
How did ECT perform over the long term?
See historical performance and comparison